We show that ANC@RNP/crEGFR‐PLK1 nanomedicine mediated efficient dual gene targeting of EGFR and PLK1 oncogenes in glioma cells with enhanced anti‐tumor effect versus single crRNA targeting of oncogenes. Here, PLK1 is linked to central nervous system cancer.